A Loxo Oncology Inc drug shown to be effective against a wide variety of cancers driven by a single, rare genetic mutation has won U.S. approval, the Food and Drug Administration announced on Monday.
Original source: http://feeds.reuters.com/~r/reuters/INhealth/~3/-LzrnMKH9uQ/loxo-bayer-drug-for-cancers-driven-by-rare-mutation-gets-u-s-nod-idINKCN1NV2OI
